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Insights in the regulation 
of trimetylamine N‑oxide 
production using a comparative 
biomimetic approach suggest 
a metabolic switch in hibernating 
bears
Thomas Ebert 1,14, Johanna Painer 2,14, Peter Bergman 3, Abdul Rashid Qureshi 1,  
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Sebastian Vetter 2, Claudia Bieber 2, Ole Fröbert 5, Jon M. Arnemo 6,7, 
Andreas Zedrosser 8,9, Irene Redtenbacher10, Paul G. Shiels11, Richard J. Johnson12 & 
Peter Stenvinkel 1,13*
Experimental studies suggest involvement of trimethylamine N‑oxide (TMAO) in the aetiology 
of cardiometabolic diseases and chronic kidney disease (CKD), in part via metabolism of ingested 
food. Using a comparative biomimetic approach, we have investigated circulating levels of the gut 
metabolites betaine, choline, and TMAO in human CKD, across animal species as well as during 
hibernation in two animal species. Betaine, choline, and TMAO levels were associated with renal 
function in humans and differed significantly across animal species. Free‑ranging brown bears 
showed a distinct regulation pattern with an increase in betaine (422%) and choline (18%) levels 
during hibernation, but exhibited undetectable levels of TMAO. Free‑ranging brown bears had 
higher betaine, lower choline, and undetectable TMAO levels compared to captive brown bears. 
Endogenously produced betaine may protect bears and garden dormice during the vulnerable 
hibernating period. Carnivorous eating habits are linked to TMAO levels in the animal kingdom. 
Captivity may alter the microbiota and cause a subsequent increase of TMAO production. Since free‑
ranging bears seems to turn on a metabolic switch that shunts choline to generate betaine instead 
of TMAO, characterisation and understanding of such an adaptive switch could hold clues for novel 
treatment options in burden of lifestyle diseases, such as CKD.
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With a global prevalence of 10–12%, chronic kidney disease (CKD) is a major health burden associated with 
increased morbidity, mortality, and reduced quality of  life1,2. When patients with CKD have progressed to 
end-stage kidney disease they exhibit high cardiovascular (CV)  mortality3,4. CKD manifests with a progeric 
 phenotype5 and the survival of incident dialysis patients is lower than that of patients with most solid-organ 
 cancers6,7. Some well-established mechanisms linking CKD with CV morbidity and mortality are  inflammation8, 
oxidative  stress9, cellular  senescence10 and metabolic  dysfunction11.
Gut microbes have been associated with CV disease (CVD) and  CKD12. Although the gut microbiota directly 
exert critical pathophysiological effects through metabolism of ingested food, it is also self-regulated by dietary 
habits and distinct disease  states12. Currently, the trimethylamine (TMA) N-oxide (TMAO) pathway (Fig. 1) is 
one of the most promising targets for a microbiota-directed treatment approach in several burden-of-lifestyle 
diseases. Gut microbiota metabolize dietary substrates to produce TMA. The essential nutrient choline can be 
directly metabolized to TMA, but also to betaine, thereby shunting away from TMAO  production13. However, 
if choline production is high, it may result in both increased TMAO and betaine production. Hence, increased 
betaine could reflect more choline generation and more TMAO production, but could also reflect a relative 
shunting of choline metabolism to the betaine pathway and away from TMAO production.
Gaseous TMA is absorbed into the circulation and subsequently oxidized to TMAO in the liver by flavin 
 monooxygenases14. While high choline and TMAO independently predicted the risk for CVD in patients under-
going elective cardiac evaluations, betaine insufficiency is associated with an adverse vascular risk profile in the 
metabolic  syndrome15,16. Moreover, low betaine was associated with components of the metabolic syndrome 
in healthy men and  women17 and betaine supplementation reduced body  fat18. Importantly, TMAO levels are 
increased in CKD, are associated with mortality risk, and induces renal  fibrosis19,20. While positive associations 
with CKD and CVD have been validated especially for  TMAO21–23, betaine’s and choline’s associations with CVD 
are mediated by  TMAO24, a finding recently validated in a meta-analysis25.
Based on ingenious solutions developed in some animal species during evolution, we have  suggested26 that 
expanding biomedical investigation to new approaches based on a broad awareness of the diversity of animal 
life and comparative physiology can accelerate innovations in human health care. Natural comparative animal 
models, such as different nutritional, seasonal and long-time fasting (such as hibernation) patterns and other 
physiologic adaptions to unfavourable environmental conditions can be used for studying metabolic regulation 
of the  microbiota27,28. Here, we investigated circulating levels of the three metabolites betaine, choline and TMAO 
(1) in patients with CKD stage 3 and 5 and healthy controls; (2) in different animal species with various dietary 
habits; (3) during hibernation and active periods in free-ranging brown bears and captive garden dormice (Eli‑
omys quercinus); (4) in free-ranging brown bears (Ursus arctos) and captive brown bears; and (5) cross-sectionally 
between CKD-prone felids compared to hibernating brown bears and human CKD patients.
Results
Betaine, choline, and TMAO in healthy subjects and patients with CKD. Basic clinical character-
istics for healthy subjects and CKD patients have been described  previously20. In all patients, median [25–75% 
interquartile range] serum betaine levels were 8.3 [7.8] ng/µl and significantly decreased with deteriorating renal 
function (p < 0.001, Fig.  2A). Thus, patients with CKD 5 had the lowest circulating betaine levels compared 
to healthy control subjects (p < 0.001) and patients with CKD stage 3 (p = 0.003, Fig. 2A). Median circulating 
choline levels were 7.2 [2.7] ng/µl in the entire human cohort. In contrast to betaine, patients with CKD 5 
showed the highest choline levels compared to healthy subjects (p = 0.07, Fig. 2B) and CKD 3 (p = 0.002, Fig. 2B). 
Serum levels of TMAO in the entire human cohort were 2.3 [5.2] ng/µl. Similar to choline, TMAO significantly 
increased in kidney disease and patients with CKD 5 had almost 13-fold and sevenfold increased TMAO levels 
compared to healthy subjects (p < 0.001, Fig. 2C) and patients with CKD 3 (p < 0.001, Fig. 2C), respectively.
Betaine, choline, and TMAO levels across species. Betaine, choline, and TMAO levels in active, free-
ranging brown bears, captive brown bears, captive garden dormice, as well as wild boars, captive lions, and cap-
tive tigers, significantly differed across all species (overall p < 0.001). Thus, active dormice showed the highest 
circulating betaine levels after correction for multiple testing (Fig. 2A). Whereas the lowest circulating choline 
levels were observed in active, free-ranging brown bears the highest choline levels were found in active garden 
Figure 1.  Proposed regulation pattern of betaine, choline, and TMAO in (A) patients with chronic kidney 
disease (CKD); (B) CKD-protected, hibernating, free-ranging brown bears; and (C) CKD-prone carnivorous 
felids, e.g. tigers. In patients with CKD (A), high levels of trimethylamine (TMA) N-oxide (TMAO) and 
choline are detectable, whereas betaine levels are low. Dietary intake of phosphatidyl-choline, betaine, TMA, 
TMAO, and L-Carnitine contribute to circulating metabolite levels. Gut microbiota can metabolize choline 
and L-Carnitine to TMA. After intestinal uptake of TMA, hepatic flavin-containing monooxygenases (FMOs) 
convert TMA into TMAO which exerts adverse cardiometabolic effects. TMAO levels in CKD are especially 
elevated due to an increased microbial TMA conversion (i.e. gut microbiota dysbiosis), as well as a reduced renal 
excretion of TMAO. In hibernating, free-ranging brown bears (B), there is no food intake and betaine, choline, 
and TMAO are endogenously produced. Based on our data, we propose a metabolic switch favouring betaine 
rather than TMAO synthesis due to increased betaine conversion from choline and reduced gut microbiota-
caused TMA production. In carnivorous animals, e.g. tigers (C), dietary intake of phosphatidylcholine, betaine, 
TMA, TMAO, and L-Carnitine contribute to circulating metabolite levels. Similar to patients with CKD, a 
metabolic switch favours TMA production by gut microbiota resulting in high TMAO levels that might be 
involved in the high CKD prevalence of carnivorous felids. Arrow size depicts increased or decreased activation 
of the respective pathway.
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Figure 2.  Circulating levels of (A) betaine, (B) choline, and (C) trimethylamine N-oxide (TMAO) in human 
subjects (black bars) with normal renal function compared to patients with chronic kidney disease (CKD) stage 
3 and 5, as well as different animal species, i.e. free-ranging, active brown bears; captive brown bears; captive, 
active garden dormice; wild boars; captive lions; and captive tigers. Animals are color-coded depending on their 
diet, i.e. omnivores (dark grey bars), and carnivores (light grey bars). Results are shown as median (interquartile 
range). Overall p values between the three groups of human subjects, as well as between animal species, were 
assessed by non-parametric Kruskal–Wallis test. Group-wise comparisons using Bonferroni post hoc analysis 
are described in the Results section. Number of participants or animals included in each group is depicted.
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dormice (Fig. 2B). Notably, TMAO was detectable in only one out of 15 free-ranging bears, but it was measurable 
in all captive bears (Fig. 2C).
Hibernation versus active summer state. To investigate the effect of hibernation on betaine, choline, 
and TMAO levels, the metabolite levels were quantified in two species during hibernation and active periods (i.e. 
free-ranging brown bears and garden dormice). During hibernation, free-ranging brown bears had significantly 
Table 1.  Characteristics of free-ranging brown bears during hibernation and the summer active state. 
Characteristics of the free-ranging brown bears during hibernation and the active state, divided into winter 
(i.e. hibernation) and summer (i.e. active) blood samplings. ALAT, Alanine transaminase; ASAT, Aspartate 
transaminase; TMAO, Trimethylamine N-oxide. Values for median (interquartile range) or total number are 
shown. p values as assessed by non-parametric Wilcoxon signed-rank test.
Hibernation winter Active summer p
N 15 15 –
Sex (male/female) 4/11 –
Age at winter sampling (years) 3.2 (1.1) –
Body weight (kg) 48 (24) 49 (26) 0.008
Albumin (g/l) 36.6 (3.4) 30.5 (3.6) < 0.001
Total protein (g/l) 74.0 (5.2) 57.5 (4.6) < 0.001
Calcium (mmol/l) 2.4 (0.1) 2.3 (0.3) 0.268
Phosphate (mmol/l) 1.5 (0.5) 2.4 (0.9) < 0.001
Total cholesterol (mmol/l) 10.4 (5.8) 6.6 (1.3) 0.063
Triglycerides (mmol/l) 4.1 (1.4) 2.1 (1.2) < 0.001
ALAT (U/l) 12.0 (3.8) 35.5 (18.0) 0.002
ASAT (U/l) 52.5 (19.8) 89.5 (51.5) 0.002
Creatinine (µmol/l) 206 (50) 84 (14) < 0.001
Urea (mmol/l) 3.5 (5.0) 13.6 (6.7) < 0.001
Uric acid (µmol/l) 65 (16) 128 (67) < 0.001
Glucose (mmol/l) 6.9 (2.1) 5.3 (3.4) 0.064
Insulin (mU/l) 2.2 (0.9) 1.5 (1.2) 0.014
Cystein (µmol/l) 134.0 (69.3) 149.4 (73.1) 0.330
CysGly (µmol/l) 20.1 (7.4) 24.6 (7.6) 0.041
Homocystein (µmol/l) 16.0 (6.8) 11.6 (12.6) 0.229
Betaine (ng/µl) 47.7 (36.5) 11.3 (6.2) < 0.001
Choline (ng/µl) 4.0 (1.4) 3.4 (0.6) 0.009
TMAO (ng/µl) 0.0 (0.0) 0.0 (0.0) –
Figure 3.  Circulating levels of (A) betaine and (B) choline in free-ranging brown bears from the longitudinal 
Scandinavian Brown Bear Research Project during hibernation, i.e. at hibernation (black bars, during winter) 
and non-hibernation (white bars, during summer). Results are shown as median (interquartile range). p values 
as assessed by non-parametric Wilcoxon signed-rank test. Number of brown bears included in each group 
is depicted. Aiming to investigate differences between hibernating and active time points, four bears were 
investigated twice in two consecutive years and treated as independent samples for this figure.
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(p < 0.05) lower body weight, liver enzymes, urea and higher albumin, total protein, triglycerides, creatinine, 
and insulin levels compared to the active summer period (Table 1). During hibernation, brown bears had 422% 
higher betaine levels (47.7 vs. 11.3 ng/µl; p < 0.001) versus the active summer period (Table 1, Fig. 3A). In con-
trast, choline levels were only 18% higher in winter (4.0 vs. 3.4 ng/µl; p = 0.009) vs. the active summer period 
(Table 1, Fig. 3B). TMAO levels were below the detection limit in all free-ranging bears during hibernation 
(Table 1). To investigate if similar changes in betaine, choline and TMAO levels were observed in another hiber-
nating species, we investigated garden dormice. In contrast to hibernating bears, hibernating (i.e. during torpor 
and interbout interval) garden dormice had significantly lower betaine (4.7 vs. 88.9 ng/µl; p < 0.05) (Fig. 4A) and 
choline (3.6 vs. 21.4 ng/µl; p < 0.001) (Fig. 4B) concentrations compared to summer active dormice with a pat-
tern similar to body temperature (Fig. 4D). TMAO levels were low during both hibernation and the active state. 
Active garden dormice, as well as garden dormice during late torpor and early interbout interval, had higher 
TMAO concentrations compared to hibernating animals in early torpor and during the intermediate interbout 
interval (all p < 0.05) (Fig. 4C).  
Free‑ranging versus captive brown bears. To investigate the impact of captivity, we compared active, 
free-ranging bears to captive bears. Free-ranging bears had significantly higher betaine levels (11.3 vs. 6.4 ng/µl; 
p < 0.001) and reduced choline levels (3.4 vs. 10.2 ng/µl; p < 0.001) compared to captive brown bears (Fig. 5A,B). 
TMAO could only be detected in one free-ranging bear, but was detected in all captive bears (0.04  ng/µl; 
p < 0.001) (Fig. 5C).
Figure 4.  Circulating levels of (A) betaine, (B) choline, (C) trimethylamine N-oxide (TMAO), and (D) body 
temperature in garden dormice at different time points during hibernation, i.e. non-hibernation (black bars), 
torpor status (grey bars, stratified into early and late torpor), and interbout interval (white bars, stratified into 
early and intermediate interbout interval). Results are shown as median (interquartile range). Overall p values 
between the five groups were assessed by non-parametric Kruskal–Wallis test. Group-wise comparisons using 
Bonferroni post hoc analysis are described in the Results section. Number of animals included in each group is 
depicted.
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Comparison between human CKD stage 3 patients and animals with “CKD‑like” sta‑
tus. Grouped by creatinine levels we compared betaine, choline, and TMAO levels between CKD 3 patients, 
free-ranging brown bears during hibernation, and felids (Table 2). Whereas felids had betaine levels comparable 
to CKD 3 patients (Fig. 6A), hibernating brown bears had significantly (p < 0.001), fourfold higher betaine levels 
than CKD 3 patients and felids (Fig. 6A). Furthermore, hibernating brown bears had significantly (p < 0.001) 
lower choline concentrations than felids and CKD 3 patients (Fig. 6B). Whereas TMAO was undetectable in 
hibernating brown bears, felids and CKD 3 patients had significantly (p < 0.001) higher TMAO levels (Fig. 6C).
Discussion
In the present study, we applied a comparative biomimetic approach to study circulating levels of betaine, choline, 
and TMAO in healthy humans, CKD patients and different mammalian species, such as captive felids (suscep-
tible to CKD) and free-ranging hibernating bears (protected against CKD). We report substantial differences 
in betaine, choline, and TMAO levels between species, dietary habits and hibernation status that provide useful 
insights when designing studies of susceptibility and protection of CKD, and other burden of lifestyle diseases, 
in relation to human lifestyle and diet (Fig. 2).
The main finding of the study was the exceptional, more than fourfold, increase in circulating betaine 
observed in free-ranging brown bears during hibernation compared to betaine levels both in the active summer 
period of free-ranging brown bears, healthy humans and other mammals (Figs. 2 and 3). Generation of betaine 
during hibernation may have multiple protective effects. During hibernation, bears are typically anuric and it 
Figure 5.  Circulating levels of (A) betaine, (B) choline, and (C) trimethylamine N-oxide (TMAO) in active, 
free-ranging brown bears (black bars) compared to captive brown bears from European zoos (grey bars). Results 
are shown as median (interquartile range). p values between the two groups were assessed by non-parametric 
Mann–Whitney U test. Number of animals included in each group is depicted. TMAO levels could only be 
detected in one out of 15 free-ranging brown bears.
Table 2.  Betaine, choline, TMAO and renal markers in CKD-susceptible felids and CKD-protected 
hibernating bears in comparison to CKD stage 3 patients. Betaine, choline, TMAO, and renal markers in 
different animal species with a chronic kidney disease (CKD)-like status, e.g. in captive lions, captive tigers, 
and hibernating, free-ranging brown bears, as well as in patients with CKD stage 3. CKD, Chronic kidney 
disease; all other abbreviations as indicated in Table 1. Values for median (interquartile range) or total number 
are shown. Continuous parameters were analysed by Kruskal–Wallis test followed by post-hoc analysis, 
whereas Chi-squared-test was used for all categorical variables. p values for overall group differences are 
depicted. Letters in superscript indicate p < 0.05 as compared to captive  lionsa, captive  tigersb, or hibernating, 
free-ranging brown  bearsc in post-hoc tests.
N
Captive lions Captive tigers
Hibernating free-ranging brown 
bears Patients with CKD stage 3
p11 11 15 30
Age (years) 5.0 (3.0) 2.5 (1.5) 3.2 (1.1) 58.7 (31.1)a,b,c < 0.001
Sex (male/female) 6/5 7/4 4/11 22/8 0.028
Body weight (kg) 155 (33) 110 (30) 48 (24)a,b 78 (20)a,c < 0.001
Body temperature (°C) 38.5 (0.9) 40.3 (1.7) 32.9 (2.0)a,b – < 0.001
Creatinine (µmol/l) 175 (81) 173 (41) 206 (50)b 173 (55)c 0.008
Urea (mmol/l) 8.5 (2.9) 7.6 (1.8) 3.5 (5.0) 14.3 (4.0)c < 0.001
Betaine (ng/µl) 7.9 (2.5) 7.5 (1.0) 47.7 (36.5)a,b 8.6 (4.3)c < 0.001
Choline (ng/µl) 9.2 (5.2) 9.2 (33.9) 4.0 (1.4)a,b 6.3 (2.6)c < 0.001
TMAO (ng/µl) 0.13 (0.16) 0.16 (0.14) 0.00 (0.00) 0.80 (0.90)a,b,c < 0.001
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has been reported that their renal blood flow decreases by 36%, while glomerular filtration rate (GFR) declines 
by 68% compared with the active  state29. Bears have developed an amazing capacity to protect their kidneys 
during hibernation, and in the spring renal function returns to normal within a couple of  weeks30,31. Better 
understanding of organ protective mechanisms during the vulnerable hibernation period may also provide 
insights into potential therapies for critically ill patients and organ injury during cold storage and reimplanta-
tion during  transplantation32.
Betaine is an anti-inflammatory and anti-oxidant essential osmoprotective nutrient involved in liver func-
tion, cellular reproduction, and cell volume  regulation33. Since a high-quality genome assembly shows that 
anti-inflammatory pathways are activated in hibernating  bears34, the anti-inflammatory potential of betaine in 
CKD deserves further study. In free-eating healthy human adults there is a negative association between intake 
of betaine (and choline) and the inflammatory  process35. As methyl groups are important for numerous cellular 
functions, such as DNA methylation, phosphatidylcholine synthesis and protein synthesis, the methyl-donor 
properties of betaine have clinical implications. Moreover, since betaine enhances lipid metabolism and improves 
insulin resistance in laboratory mice (Mus musculus f. domesticus) fed a high-fat  diet36, high betaine levels may 
play a role in the healthy obese  phenotype37 observed in bears preparing for  hibernation38. As betaine has protec-
tive effects on isoprenaline-induced renal failure in rats (Rattus norvegica f. domesticus) via a decrease in tumour 
necrosis factor and nitric oxide  synthase39, high betaine levels may also protect kidneys during hibernation. 
Our observation of lower betaine levels in CKD (Fig. 2) and the finding that betaine inhibits cell proliferation 
and extracellular matrix  deposition40 supports a renal protective effect for betaine. During hibernation bears 
Figure 6.  Circulating levels of (A) betaine, (B) choline, (C) trimethylamine N-oxide (TMAO), and (D) 
creatinine in human subjects with chronic kidney disease (CKD) stage 3 (black bars) compared to different 
animal species with a CKD-like status, i.e. free-ranging brown bears during hibernation (dark grey bars), as well 
as captive lions and tigers (light grey bars). Results are shown as median (interquartile range). Overall p values 
between the four groups were assessed by non-parametric Kruskal–Wallis test. Group-wise comparisons using 
Bonferroni post hoc analysis are described in the Results section. Number of subjects/animals included in each 
group is depicted. TMAO levels could not be detected in hibernating free-ranging brown bears.
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should be at high risk (physiologic kidney insufficiency + no intake of B-vitamin) of hyperhomocysteinemia; 
an established risk factor for CV, cerebrovascular and neurodegenerative  disease41. However, as we observed 
no significant increase in homocysteine levels during hibernation (Table 1), high betaine may protect against 
hyperhomocysteinemia by re-methylation of  homocysteine42. Accordingly, homocysteine does not elevate in bat 
(Myotis pilosus) brains during torpor due to increased expression of betaine-homocysteine S-methyltransferase43. 
As betaine is an osmolyte that protects proteins, cells and enzymes from environmental stress, such as extreme 
temperature and lack of water in  animals44 and  plants45, betaine may have protective effects when organisms are 
under environmental stress.
It has been reported that betaine improves animal performance and increases lean body mass, meat quality, 
and reduces fat deposits in meat-producing cattle, pigs and  poultry18,46,47. Thus, high betaine during hiberna-
tion may protect the bears’ lean body mass and enhance lipolysis, important for energy supply. In humans, high 
dietary choline and betaine intake have been significantly associated with favourable body  composition48. The 
impact of the endogenous microbiota may be significant in this respect in man. While humans have a synthetic 
capacity for betaine, this is supplemented via nutritional acquisition of substrates and subsequent conversion to 
betaine by gut microbes. Seasonal changes in the gut microbiota in bears, with the ability to transfer seasonal 
metabolic characteristics to germ-free mice via fecal transplants have previously been  reported49. As choline and 
other methyl donors regulate methylation of genes related to memory and cognitive  functions50, high betaine 
and choline levels may also protect their brain during hibernation. In addition to serving as an osmolyte and 
metabolic intermediate, betaine influences pathways of inhibitory neurotransmitter production-recycling51.
The reason(s) why free-ranging bears can give birth and lactate (conditions associated with high metabolic 
demand) during  hibernation52, are likely physiological and behavioural adaptations through which offspring 
survive harsh seasonal conditions, such as inclement weather or low food  availability53–55. The successful develop-
ment of the fetus depends on optimal dietary intake of folate, choline and betaine involved in one-carbon transfer 
methylation and related epigenetic effects on gene  expression56. Moreover, maternal and postnatal dietary methyl 
nutrients have effects on the epigenetic machinery that in adulthood may lead to non-communicable  diseases57. 
As the supply of methyl groups is vital during pregnancy, we speculate that high levels of betaine protect the 
fetuses in pregnant bears during hibernation. Indeed, betaine plays an important role in physiologic  pregnancy58, 
fetal  development59,60 and DNA  methylation61. Furthermore, in dairy cattle, betaine supplementation increase 
lactation  performance62.
The mechanism(s) by which betaine and choline levels increase during the long period of fasting are unclear. 
However, in part, the increase may reflect an excessive intake of betaine-rich food in the autumn in preparation 
for hibernation. As betaine is found in microorganisms, plants, and animal muscle, it is a significant compo-
nent of many foods. The daily intake of betaine in the human diet ranges from an average of 1 g/d to a high of 
2.5 g/d. Nutrients rich in betaine include wheat bran (1339 mg/100 g), wheat germ (1241 mg/100 g), spinach 
(645 mg/100 g), shrimp (218 mg/100 g), and wheat bread (201 mg/100 g)63. Although some bears in our study 
area do eat wheat during spring and early  summer64, betaine-rich foods are not part of the typical diet of free-
ranging Scandinavian brown bears, which on an annual basis usually consists of 50% protein (ants, ungulate 
carcasses) that is mainly consumed in spring, and 50% carbohydrates (berries) that is mainly consumed in 
summer and  fall65. The betaine content in bilberries is rather low (0.2 mg/100 g)63. However, since free-ranging 
bears during hyperphagia can eat a massive amount of different berries per day a significant amount of betaine 
will be ingested in the peak season. As increased intake of betaine- and choline-rich food in the autumn is 
unlikely to increase circulating betaine as much as fourfold, a metabolic switch that increase endogenous pro-
duction of choline is likely to occur before and under hibernation. Since ≈30% of phosphatidylcholine can be 
produced by the sequential methylation of phosphatidyl-ethanolamine (via PE-methyltransferase), the body has 
the capacity to make choline ´de novo’66. Similarly, Olthof et al.67 have shown that supplementation of choline, 
as phosphatidylcholine, increases the pool of choline for the production of betaine. Thus, since phospholipids 
and phosphatidyl-ethanolamine could be used as an endogenous source for choline, further studies need to 
investigate these metabolic events in hibernating  mammals68.
Beside bears, only few mammals and birds are known to give birth and lactate during  hibernation69. To 
investigate if high levels of betaine during hibernation are specific for bears or a feature of temperature changes, 
we studied garden dormice—another hibernating species. In contrast to bears’ constant hibernation body tem-
perature, dormice have to periodically rewarm from cold torpid states to warm interbout  intervals70. We find 
that whereas betaine and choline are not generated in dormice at 5 °C they are rapidly generated at 37 °C despite 
fasting (Fig. 4). This supports the hypothesis of a metabolic switch with endogenous betaine production as cell-
protective substance during warming-up periods. The torpor-arousal switch is characterized by the accumulation 
of metabolites of nitrogen (glutamine) and phospholipid (betaine) catabolism in late torpor with the capacity 
to act as protective  osmolytes71.
In contrast to free-ranging hibernating bears, which are protected against CKD and the CKD complications 
observed in the human uremic phenotype, such as osteoporosis, sarcopenia and  arteriosclerosis30, wild and 
domestic felids are susceptible to  CKD72 and  arteriosclerosis73. The prevalence of CKD in domestic cats (Felis 
catus) is high (estimated to affect 1/3 of older cats) and has increased in recent  decades72. The tubulointerstitial 
changes, including fibrosis, that are present in the early stages of feline CKD become more severe in advanced 
 disease72. As transforming growth factor (TGF)-β1 is involved in epithelial cell de-differentiation, growth arrest 
and apoptosis in feline CKD, it has been suggested that feline CKD is a useful, naturally occurring model of 
human  CKD74. The prevalence of CKD in wild felids is not well studied. However, a recent thesis concluded that 
CKD is a prevalent disease affecting non-domestic felids throughout zoos in  Australia75. In accordance, a study 
of captive wild felids at German zoos, showed that renal lesions were detected in 33 out of 38  animals76. A variety 
of factors—including ageing, ischemia, comorbidities and high phosphorus overload due to a carnivorous diet 
have been implicated as factors that promote felid  CKD72.
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Gut microbial metabolism of dietary choline, a nutrient abundant in the Western diet, produces TMA and 
the atherothrombosis- and fibrosis-promoting metabolite TMAO. High TMAO levels are mechanistically linked 
to  atherosclerosis77 and increase the risk for premature  CVD78. The high TMAO levels reported in CKD are due 
to both impaired renal  function20 and gut dysbiosis with higher percentages of opportunistic  pathogens79. As 
TMAO promotes interstitial  nephritis80, we measured TMAO in felids (Fig. 6). High intake of red meat (espe-
cially processed and red meat) has been associated with increased risk of  CKD81 and premature ageing in the 
general  population82. Chronic dietary exposures of red meat increase TMAO levels via modulation of the gut 
 microbiota83. We compared CKD 3 patients with felids and hibernating brown bears with comparable levels 
of S-creatinine (Table 2) and report major differences in betaine and TMAO levels (Fig. 6). Both  fasting84 and 
 hibernation85 alter the gut microbiota. As TMAO was not detectable in free-ranging active bears (except one) 
this suggests that free-ranging brown bears do not synthesize TMA due a “healthy” gut microbiota. It is notice-
able that of the eight species of bacteria from two main phyla (Firmicutes and Proteobacteria) that use choline 
for production of  TMA86 none was reported in a study of bear microbiota composition in relation to seasonal 
changes in energy  metabolism49. TMAO promotes vascular  calcification87 and the absence of TMAO in free-
ranging bears may contribute to their low risk of arteriosclerosis despite massive  hypercholesterolemia68.
In contrast to free-ranging bears, TMAO was measurable in all captive bears, likely related to different food 
habits associated with altered gut microbiota. As captivity and domestication have dramatically reshaped the 
gastrointestinal microbiota in numerous species, e.g. in wild and domestic  equids88, free-ranging and captive 
Andean bears (Tremarctos ornatus)89, and  primates90, loss of diversity (and maybe infection of human micro-
biota from animal keepers) most likely occurs in captive brown bears, which contributes to the generation of 
TMAO. Higher Firmicutes to Bacteroidetes enrichment leads to a greater response to dietary TMAO precursor 
 intake91. Thus, differences in microbial composition between humans and the other species likely contribute to 
the observed difference. As fermented food lowers TMAO levels in healthy  adults92, a difference in the amount of 
ingested fermented food could also contribute to observed differences. To the best of our knowledge, circulating 
TMAO levels have not previously been measured in a comparative human–animal study. However, high levels of 
TMAO in muscle tissue have been reported in marine  mammals93. As muscle TMAO contents increase linearly 
with depth in six fish  families94, it has been suggested that TMAO counteracts protein-destabilizing forces in 
deep-sea water. We report that circulating TMAO levels are higher in omnivorous healthy humans compared to 
other species (Fig. 2C). As humans are the only species in this study that eats fish on a regular basis, this could 
contribute to higher TMAO levels. Plasma TMAO concentrations were directly associated with dairy consump-
tion and low-grade  inflammation95 and in vegans/vegetarians the transformation into TMA via low-abundance 
microbiota occurs at a markedly lower extent compared to  omnivores96.
The results of this descriptive study should be interpreted taking a number of caveats into account. Firstly, the 
number of healthy controls, CKD patients and animal species are limited. However, even with this rather limited 
number we have observed major differences between the species. Our sample numbers were, however, too small 
to enable sex-specific statistics. Secondly, the free-ranging and captive bears were not matched for weight and 
age. Thirdly, as we do not have information on dietary habits in healthy controls, CKD patients and free rang-
ing bears we cannot relate our findings to dietary exposures. Our study would also have benefited by faecal or 
circulatory microbiota cultures in the different species. Creatinine, a by-product of muscle catabolism excreted 
by the kidneys, is considered a reliable index for kidney function. However, as S-creatinine is also affected by 
muscle mass and meat intake it is possible that higher muscle mass and the carnivorous diet contributes to high 
S-creatinine levels in tigers and lions.
In conclusion, this comparative biomimetic study suggests that a metabolic switch leading to endogenously 
produced betaine protects bears and garden dormice during the vulnerable hibernation period. Our data also 
show that carnivorous eating habits in the animal kingdom are linked to higher TMAO levels. Furthermore, we 
show a strong association between body temperature and the endogenous production of betaine and the deple-
tion of TMAO. The characterization and manipulation of a metabolic switch that divert choline to generation 
of betaine instead of TMAO would likely have a major impact in prevention of not only CKD but also other 
burden of lifestyle diseases.
Materials and methods
Chronic kidney disease patients and healthy controls. Fasting plasma samples from Caucasian CKD 
stage 3 (eGFR 30–60 ml/min; n = 30) and stage 5 (eGFR < 15 ml/min; n = 121) patients, consecutively recruited 
into two observational prospective cohort studies, were analysed for betaine, choline, and TMAO. Part of these 
data have previously been  published20. Exclusion criteria were age < 18 years, active hepatitis B/C, HIV or signs 
of acute infection. The Ethics Committee of the Karolinska Institutet approved the study protocol (244/01, 
2007/1663-31/4, 2016/1470-31/4) and informed written consent was obtained from all patients. Eighty age- and 
sex-matched population-based individuals in the Stockholm region of Sweden, randomly selected by Statistics 
Bureau of Sweden (www.scb.se) served as controls. No other exclusion criteria than unwillingness to participate 
in the study were applied in the selection of the healthy controls.
Animal cohorts:. Free‑ranging brown bears (Ursus arctos). The Scandinavian Brown Bear Research Pro-
ject is a long-term individual-based ecological study of brown bears in central Sweden. All animal handling 
and sampling was approved by the Swedish Ethical Committee on Animal Experiments (application numbers 
C212/9 and C47/9) and the Swedish Environmental Protection Agency. Study protocols and procedures have 
been described  previously31. Briefly, blood samples were obtained from 15 free-ranging, sub-adult, 2- to 3-year-
old Eurasian brown bears (Ursus arctos) (11 females, mean body weight in winter: 47 kg; four males, mean body 
weight in winter: 35 kg) in Dalarna County, Sweden, 2010–2012. For this purpose, each bear was captured dur-
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ing hibernation, i.e. in February or March, as well as during the active period in June of the same year. Bears 
were anesthetized by darting with a combination of tiletamine–zolazepam (1.1 mg/kg), medetomidine (0.03 mg/
kg) and ketamine (hibernating animals) or tiletamine–zolazepam (4.7 mg/kg) and medetomidine (0.09 mg/kg) 
(active animals)31,97. All blood samples were taken from the jugular vein and approximately 1 h after sampling, 
blood was centrifuged and subsequently immediately frozen on dry ice until storage at − 70 °C31.
Captive brown bears. The captive European brown bears were sampled during regular veterinary health checks. 
The animals were housed in large, naturalistic enclosures (> 5.000  m2) in Germany, Poland, Kosovo, and Sweden. 
Only blood samples from healthy individuals were included in this study. Their diet consisted, besides foraging 
of grass in the enclosure, mainly vegetables, fruits, eggs, and nuts. Occasionally the animals received wild ungu-
late meat, dog-pellets, berries, and bread. Sampling took place under general anesthesia with ketamine (2.2 mg/
kg), medetomidine (0.035 mg/kg), midazolam (0.05 mg/kg), and butorphanol (0.05 mg/kg), after being starved 
for 10–12 h, with water ad libitum until injection. The jugular vein was used for fasting blood sampling in all 34 
bears (18 females, mean body weight: 150 kg; 16 males, mean body weight: 234 kg, age-range 2–16 years old).
Garden dormice. The animals involved were part of a different study on  hibernation98 (Austrian Federal 
Ministry of Education, Science and Research license number 68.205/0137-WF/V/3b/2014) and reviewed and 
approved by the institutional ethics committee of the Veterinary University in Vienna, Austria and the relevant 
Austrian authority in accordance with the Austrian Animal Experimentation Act. The garden dormice issued 
from a breeding colony were kept at the Research Institute of Wildlife Ecology (Vienna, Austria). They were 
housed in cages equipped with one nest, bedding and nesting material, and kept under natural fluctuations of 
ambient temperature and photoperiod. During hibernation, they were kept at 4 °C in ventilated cooling units 
within a customized nest and bedding material under constant darkness. During pre-hibernation period the 
animals were fed protein pellets (commercially available, processed cat food pellets) enriched with poly-unsat-
urated fatty acids (PUFAs), linseed, and safflower oil. Fasting blood sampling took place post-mortem from 
the heart. About 23 dormice (mean body weight: 118.2 g) were sacrificed in active status, whereas 23 different 
animals (mean body weight: 107.0 g) were investigated in torpor status of hibernation (N = 14 early torpor; N = 9 
late torpor), as well as 19 other dormice (mean body weight: 105.4 g) that were euthanized in interbout interval 
during hibernation (N = 11 early interbout interval; N = 8 intermediate interbout interval).
Captive lions and tigers. Twenty-two animals (11 lions and 11 tigers) were sampled during standard, random 
veterinary health checks and only healthy individuals were included in the study. The individuals were housed 
in zoological parks in Europe and fed a standard large carnivore diet consisting of mainly red meat (beef and 
horse meat), bones, occasional white meat (chicken), and calcium powder. Six male (mean body weight: 178 kg) 
and five females (mean body weight: 148 kg) lions, as well as seven male (mean body weight: 110.6 kg) and four 
female tigers (mean body weight: 124.3 kg), were available for the present analysis. Mean age of the lions and 
tigers was 4.9 and 3.2 years, respectively. All animals were immobilized with a combination of 3.5 mg/kg keta-
mine, 0.035 mg/kg medetomidine, 0.1 mg/kg midazolam, and 0.05 mg/kg butorphanol. Fasting blood sampling 
was obtained from the jugular vein. None of the lions and tigers were pregnant at the time of blood sampling 
and no contraceptive methods were used. All use of samples from tigers and lions were reviewed and approved 
by the institutional ethics committee of the Veterinary University of Vienna, Austria.
Wild boars (Sus scrofa). The animal study was reviewed and approved by the institutional ethics committee of 
the Veterinary University in Vienna, Austria and the relevant Austrian authority in accordance with the Austrian 
Animal Experimentation Act (Austrian Federal Ministry of Education, Science and Research license numbers 
68.205/0224-WF/V/3b/2016 and 68.205/0159-WF/V/3b/2016). Animals were kept under naturalistic condi-
tions in a large acorn forest and supplementary fed with ~ 1.2 kg/animal/day of corn. Details on housing and 
handling of the animals have been described  previously99. Ten 6-year-old, non-pregnant females were available 
for the present study. The animals were immobilized using a combination of 3.2 mg/kg tiletamine–zolazepam, 
0.07 mg/kg medetomidine, and 0.15 mg/kg butorphanol.
Assays. All methods were performed in accordance with relevant guidelines and regulations for humans 
and animals. In human subjects, plasma heparin samples were obtained after a 12 h fast and stored at − 80 °C 
prior to measurements. In brown bears, garden dormice, captive lions and tigers, as well as wild boars, blood 
samples were taken as indicated in the respective section. Quantification of betaine, choline, and TMAO was 
performed by Liquid chromatography with tandem mass spectrometry with a previously published protocol in a 
96-well  format22. In more detail, plasma aliquots were spiked with internal standards, comprised of TMAO-D9, 
betaine-D9, and choline-D9 in 80% methanol. The metabolite extract was collected, 20 µL was transferred to a 
96 well plate, and evaporated to dryness. Before analysis, the samples were dissolved in 100 µL 50% MeOH with 
13C5-proline as a recovery standard, and subsequently injected into an Agilent 1290 Infinity chromatographic 
system (Agilent Technologies, Waldbronn, Germany) fitted with an Acquity UPLC Amide column in combina-
tion with a VanGuard precolumn (Waters Corporation, Milford, MA). Detection of the metabolites was per-
formed using an Agilent 6490 Triple Quadrupole mass spectrometer (Agilent Technologies, Santa Clara, CA). 
Data processing was done by MassHunter Quantitative Analysis QQQ (Agilent Technologies Inc. Santa Clara, 
CA). Importantly, we have previously demonstrated that metabolite levels remain stable and are comparable 
when using either plasma heparin and serum samples and multiple number of freeze–thaw  cycles22. All other 
parameters in the free-ranging bears, as well as in the captive tigers and lions, were quantified in our in-house 
lab (Karolinska Institutet, Stockholm, Sweden). Insulin was measured using an enzyme linked immunosorb-
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ent assay according to the manufacturer’s instructions (Iso-Insulin, #10-1128-01, Mercodia, Uppsala, Sweden). 
Cystein, cysteinylglycin, and homocystein levels were measured by HPLC as modified from Ubbink et al.100. 
Routine parameters, including albumin, total protein, total cholesterol, triglycerides, liver enzymes, markers 
of renal function, and electrolytes were measured using a fully automated, random access analyser (Konelab, 
Thermo Fisher Scientific, Vantaa, Finland).
Statistical analysis. SPSS software version 26.0 (IBM, Armonk, NY) and GraphPad Prism 8 (GraphPad 
Software, San Diego, CA) were used for all statistical analyses. Overall group differences between the three 
human subgroups (healthy subjects, CKD 3 subjects, CKD 5 subjects), between different species and diets, as 
well as between animals with CKD-like status (hibernating bears and felids) and human patients with CKD, 
were assessed by non-parametric Kruskal–Wallis test with Bonferroni post hoc analyses for group-wise com-
parisons, respectively. Longitudinal data in the Scandinavian Brown Bear Research Project on hibernation com-
pared to non-hibernation periods were analysed using non-parametric Wilcoxon signed-rank test. Comparisons 
between captive and free-ranging bears were calculated using non-parametric Mann–Whitney U test. A p value 
of < 0.05 was considered as statistically significant in all analyses.
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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